IGF1R and breast carcinoma: Since IGF-1R has been described as an anti-apoptotic factor in breast cancer cells, increased apoptosis observed in TFPI-stimulated MDA-MB-231 cells may be a consequence of diminished IGF-1R levels as a result of TF pathway inhibition.